We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Device Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Keywords » Daily International Pharma Alert

Items Tagged with 'Daily International Pharma Alert'

ARTICLES

Kenya May Consider HIV Drug Compulsory Licensing

April 13, 2007

Kenya is the latest country to assert that it will not let international patent protection restrict access to life-saving medicines, including HIV drugs, according to a report from the U.N. Integrated Regional Information Networks (IRIN).

Read More

FDA Advisory Committee Rejects Merck's Arcoxia

April 13, 2007

The FDA's Arthritis Advisory Committee voted 20-1 against recommending approval of Merck's Arcoxia, a potential successor to Vioxx as a treatment for arthritis pain.

Read More

MHRA Considers Widening Availability of Naproxen

April 13, 2007

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has issued a public consultation on whether naproxen 250-mg tablets should be made available OTC for treating primary dysmenorrhoea, or period pain, for women ages 15 to 50.

Read More

Australia to Subsidize New ADHD Drug

April 13, 2007

A new drug for treating attention-deficit/hyperactivity disorder (ADHD) will be listed on Australia's Pharmaceutical Benefits Scheme (PBS) starting July 1, the Ministry of Health and Ageing announced.

Read More

Groups Call on Health Ministers to Boost HIV Treatment Coverage

April 12, 2007

A weeklong meeting of African Union (AU) health ministers is under way in Johannesburg, South Africa, and activists have expressed concern that commitments on HIV/AIDS made at meetings last year are missing from the agenda, the U.N. Integrated Regional Information Networks (IRIN) reports.

Read More

AstraZeneca Sues Novartis Over Generic Seroquel

April 12, 2007

AstraZeneca is suing Novartis subsidiary Sandoz to block it from marketing generic Seroquel, documents filed in U.S. federal court last week revealed.

Read More

Gilead Sciences to Invest 60 Million Euros in New Irish Facility

April 12, 2007

Gilead Sciences is planning to invest 60 million euros in developing a new world-class pharmaceutical plant in Dublin, Ireland, the country's Minister for Enterprise, Trade and Employment Micheál Martin announced.

Read More

PhRMA Supports Fighting Counterfeit Drugs in China

April 12, 2007

In response to the U.S government's request for a World Trade Organization panel to investigate intellectual property rights enforcement in China, the Pharmaceutical Research and Manufacturers of America (PhRMA) issued a statement saying the move shows the U.S. government's commitment to fighting counterfeit drugs.

Read More

Health Ministers Discuss Producing Drugs in Africa

April 11, 2007

This week, the African Union (AU) is holding a Conference of Ministers of Health in Johannesburg, South Africa, to discuss strengthening the continent's health systems.

Read More

Abbott Moves Humira Manufacturing to Puerto Rico

April 11, 2007

Abbott Laboratories' new Barceloneta, Puerto Rico, manufacturing facility will be the primary production facility for the TNF inhibitor Humira, the firm announced.

Read More
More Articles Tagged with 'Daily International Pharma Alert'

Upcoming Events

  • 10Mar

    FDA Drug GMP Facility Inspections During the Pandemic

  • 16Mar

    Pharmaceutical Naming Regulation: Understanding the Latest Developments

  • 18Mar

    Pharmaceutical Postmarket Surveillance: Latest Developments in the Era of COVID-19

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 30Mar

    Data Integrity for GMP/Postmarket Professionals: Core Requirements, Expectations and Challenges

  • 06Apr

    Medical Device Cybersecurity: Understand the Latest Developments

Featured Products

  • Biological Risk Evaluation and Management for Medical Devices

  • GMP Inspection Preparation Checklist: A Tool for Internal Auditing

Featured Stories

  • Sanofi-Regeneron_Logos.png

    Sanofi’s and Regeneron’s Libtayo Wins FDA Approval for NSCLC

  • PerkinElmer logo

    PerkinElmer’s Rapid Point-of-Care COVID-19 Test Cleared in Europe

  • WhiteHouse.gif

    President Biden Issues Executive Order on U.S. Supply Chain

  • roche.gif

    Priority Healthcare Settles Diabetes Test Lawsuit with Roche for $43 Million

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing